CRDL
Price
$1.46
Change
+$0.02 (+1.39%)
Updated
Jun 13 closing price
Capitalization
124.33M
65 days until earnings call
OGI
Price
$1.40
Change
-$0.07 (-4.76%)
Updated
Jun 13 closing price
Capitalization
200.85M
Interact to see
Advertisement

CRDL vs OGI

Header iconCRDL vs OGI Comparison
Open Charts CRDL vs OGIBanner chart's image
Cardiol Therapeutics
Price$1.46
Change+$0.02 (+1.39%)
Volume$177.05K
Capitalization124.33M
Organigram Global
Price$1.40
Change-$0.07 (-4.76%)
Volume$855.94K
Capitalization200.85M
CRDL vs OGI Comparison Chart
Loading...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRDL vs. OGI commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDL is a Hold and OGI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (CRDL: $1.46 vs. OGI: $1.40)
Brand notoriety: CRDL and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRDL: 94% vs. OGI: 162%
Market capitalization -- CRDL: $124.33M vs. OGI: $200.85M
CRDL [@Pharmaceuticals: Other] is valued at $124.33M. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDL’s FA Score shows that 0 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • CRDL’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, OGI is a better buy in the long-term than CRDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDL’s TA Score shows that 4 TA indicator(s) are bullish while OGI’s TA Score has 4 bullish TA indicator(s).

  • CRDL’s TA Score: 4 bullish, 3 bearish.
  • OGI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRDL is a better buy in the short-term than OGI.

Price Growth

CRDL (@Pharmaceuticals: Other) experienced а +3.55% price change this week, while OGI (@Pharmaceuticals: Other) price change was +3.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.42%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +67.02%.

Reported Earning Dates

CRDL is expected to report earnings on Aug 18, 2025.

OGI is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.42% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OGI($201M) has a higher market cap than CRDL($124M). CRDL YTD gains are higher at: 14.063 vs. OGI (-13.043). CRDL has higher annual earnings (EBITDA): -30.61M vs. OGI (-195.74M). OGI (42.3M) and CRDL (40.5M) have equal amount of cash in the bank . OGI has less debt than CRDL: OGI (136K) vs CRDL (181K). OGI has higher revenues than CRDL: OGI (161M) vs CRDL (0).
CRDLOGICRDL / OGI
Capitalization124M201M62%
EBITDA-30.61M-195.74M16%
Gain YTD14.063-13.043-108%
P/E RatioN/AN/A-
Revenue0161M-
Total Cash40.5M42.3M96%
Total Debt181K136K133%
FUNDAMENTALS RATINGS
CRDL vs OGI: Fundamental Ratings
CRDL
OGI
OUTLOOK RATING
1..100
2420
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9692
PRICE GROWTH RATING
1..100
4441
P/E GROWTH RATING
1..100
10036
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (50) in the null industry is somewhat better than the same rating for CRDL (97). This means that OGI’s stock grew somewhat faster than CRDL’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as CRDL (100). This means that OGI’s stock grew similarly to CRDL’s over the last 12 months.

OGI's SMR Rating (92) in the null industry is in the same range as CRDL (96). This means that OGI’s stock grew similarly to CRDL’s over the last 12 months.

OGI's Price Growth Rating (41) in the null industry is in the same range as CRDL (44). This means that OGI’s stock grew similarly to CRDL’s over the last 12 months.

OGI's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for CRDL (100). This means that OGI’s stock grew somewhat faster than CRDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDLOGI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JTKWY4.44-0.02
-0.51%
Just Eat Takeaway.com N.V.
ADRNY41.23-0.27
-0.65%
Koninklijke Ahold Delhaize N.V.
BBKCF0.09N/A
-2.16%
BIGG Digital Assets Inc.
NSRGF102.39-3.04
-2.88%
Nestle S.A.
GELYF2.08-0.07
-3.26%
Geely Automobile Holdings Ltd.